Catherine E Greer

Title: The Innovative Contributions of Catherine E Greer

Introduction

Catherine E Greer is a prominent inventor based in Oakland, CA, known for her significant contributions to the field of molecular biology. With a total of five patents to her name, she has made remarkable advancements in the detection of human papillomavirus (HPV) through innovative methodologies.

Latest Patents

Greer's latest patents focus on the detection of human papillomavirus by utilizing the polymerase chain reaction (PCR). This method allows for the amplification of HPV DNA sequences, enabling the identification and typing of HPV present in various samples. The use of consensus primers facilitates the amplification of specific regions of the HPV genome, while the presence of amplified DNA indicates the presence of HPV. Furthermore, the HPV nucleic acid is detected using consensus probes, which can be either short oligonucleotide probes or long generic probes. The typing of HPV is achieved through type-specific DNA probes that target the amplified DNA region.

Career Highlights

Throughout her career, Catherine E Greer has worked with notable companies such as Hoffmann-La Roche Inc. and Roche Molecular Systems, Inc. Her work has significantly impacted the field of virology and diagnostics, particularly in the context of HPV detection.

Collaborations

Greer has collaborated with esteemed colleagues, including Heidi M Bauer and M Michele Manos, contributing to the advancement of research in her field.

Conclusion

Catherine E Greer's innovative work in the detection of human papillomavirus has established her as a key figure in molecular diagnostics. Her contributions continue to influence the landscape of virology and public health.